{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:19:02Z","timestamp":1773933542190,"version":"3.50.1"},"reference-count":58,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: We tested whether a contrast-free protocol can reproduce contrast-enhanced VI-RADS scoring and whether reader expertise influences results. Methods: In this retrospective single-center study (January\u2013December 2024), 65 patients (69 lesions) underwent bladder multiparametric MRI. Two blinded radiologists assigned VI-RADS scores using only T2-weighted and diffusion-weighted imaging (biparametric, non-contrast MRI): an expert (&gt;15 years in urogenital radiology) in genitourinary MRI and a non-expert (5 years of experience in genitorurinary radiology). Two complementary reference standards were used. For reproducibility analysis, the reference standard was the VI-RADS score from the original clinical report based on the full multiparametric examination including contrast-enhanced imaging. For diagnostic accuracy analysis, histopathology was used as the reference standard for muscle-invasive versus non-muscle-invasive disease. Agreement was evaluated with confusion matrices, overall agreement, and weighted Cohen\u2019s kappa. Discrimination for high likelihood of muscle invasion (VI-RADS \u2265 4) was assessed with receiver operating characteristic analysis. Results: Reference scores were VI-RADS 2 (34.8%), 3 (14.5%), 4 (20.3%), and 5 (30.4%). Agreement was higher for the expert than the non-expert (73.9% vs. 56.5%; weighted kappa 0.74 [95% confidence interval 0.56\u20130.89] vs. 0.58 [0.37\u20130.75]). The area under the curve for VI-RADS \u2265 4 was 0.87 (0.78\u20130.95) for the expert and 0.81 (0.69\u20130.91) for the non-expert. Sensitivity at a biparametric threshold of VI-RADS \u2265 4 was 88.6% for both readers; specificity was 85.3% vs. 73.5%. Post-resection cases showed more discrepancies, mainly overstaging. Conclusions: Contrast-free biparametric MRI may approximate multiparametric VI-RADS scoring only in treatment-na\u00efve pre-TURBT cases with clearly low-risk, non-equivocal imaging features, but performance is reader-dependent and less reliable in equivocal, higher-risk, and post-resection examinations. Contrast-enhanced multiparametric MRI remains preferred for staging.<\/jats:p>","DOI":"10.3390\/cancers18060999","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:49:24Z","timestamp":1773924564000},"page":"999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biparametric Versus Multiparametric MRI for VI-RADS Assessment: Reproducibility Relative to Routine mpMRI Reporting and Impact of Radiologist Experience in a Single-Center Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Fabrizio","family":"Urraro","sequence":"first","affiliation":[{"name":"Department of Life Sciences, Health and Health Professions, Link Campus University, 00165 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Luigi Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0767-3884","authenticated-orcid":false,"given":"Vittorio","family":"Patan\u00e8","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Luigi Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Brunese","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Luigi Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rossi","sequence":"additional","affiliation":[{"name":"Radiology Department, CTO Hospital, AORN dei Colli, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cioffi","sequence":"additional","affiliation":[{"name":"Department of Urology, Ospedale del Mare, 80147 Napoli, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Luigi Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Varelli","sequence":"additional","affiliation":[{"name":"Radiology Unit, Istituto Diagnostico Varelli, 80126 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiammetta","family":"Cappabianca","sequence":"additional","affiliation":[{"name":"School of Medicine, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-6235","authenticated-orcid":false,"given":"Alfonso","family":"Reginelli","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, Piazza Luigi Miraglia 2, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tortora, F., Guastaferro, A., Barbato, S., Febbraio, F., and Cimmino, A. (2024). New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities. Sensors, 24.","DOI":"10.3390\/s24247873"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s41043-025-01113-9","article-title":"Diseases burden and trends of bladder cancer attributable to behavioral and metabolic factors among global and Chinese population, 1990\u20132021: Results from the global burden of disease study 2021","volume":"44","author":"Liu","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1038\/s41598-025-92033-5","article-title":"Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: An observational study from the global burden of disease study 2021","volume":"15","author":"Su","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00345-025-05960-3","article-title":"Management of clinical stage T3\/T4 bladder cancer: A review","volume":"43","author":"Escobar","year":"2025","journal-title":"World J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E15734056377754","DOI":"10.2174\/0115734056377754250304040058","article-title":"A Machine Learning Model Based on Multi-Phase Contrast-enhanced CT for the Preoperative Prediction of the Muscle-Invasive Status of Bladder Cancer","volume":"21","author":"He","year":"2025","journal-title":"Curr. Med. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25131","DOI":"10.1038\/s41598-024-77101-6","article-title":"Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN","volume":"14","author":"Shalata","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_9","first-page":"e90077","article-title":"Integrated Magnetic Resonance Imaging in Muscle-Invasive Bladder Cancer: A Comprehensive Review","volume":"17","author":"Ibraheem","year":"2025","journal-title":"Cureus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"421709","DOI":"10.1155\/2012\/421709","article-title":"Surveillance and treatment of non-muscle-invasive bladder cancer in the USA","volume":"2012","author":"Barocas","year":"2012","journal-title":"Adv. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Damaj, N., Naim, N., Saad, A., Kattan, C., and Kattan, J. (2025). Management of bladder cancer recurrence following the trimodality therapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1672431"},{"key":"ref_12","first-page":"61.e61","article-title":"Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy","volume":"40","author":"Kufukihara","year":"2022","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e100002","DOI":"10.1136\/bmjopen-2025-100002","article-title":"Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: Study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study)","volume":"15","author":"Grutters","year":"2025","journal-title":"BMJ Open"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Guldhammer, C.S., V\u00e1squez, J.L., Kristensen, V.M., Norus, T., Nadler, N., Jensen, J.B., and Azawi, N. (2024). Cystoscopy Accuracy in Detecting Bladder Tumors: A Prospective Video-Confirmed Study. Cancers, 16.","DOI":"10.3390\/cancers16010160"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41585-024-00904-9","article-title":"Optimizing cystoscopy and TURBT: Enhanced imaging and artificial intelligence","volume":"22","author":"Shkolyar","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, W., Wu, J., Shen, Q., Li, W., Xue, K., Yang, Y., and Qiu, J. (2024). Assessment of pathological grade and variants of bladder cancer with a continuous-time random-walk diffusion model. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1431536"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Reginelli, A., Patan\u00e8, V., Urraro, F., Russo, A., De Chiara, M., Clemente, A., Atripaldi, U., Balestrucci, G., Buono, M., and D\u2019Ippolito, E. (2023). Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study). Diagnostics, 13.","DOI":"10.3390\/diagnostics13142334"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00384-025-04969-9","article-title":"MRI-based radiomics for preoperative T-staging of rectal cancer: A retrospective analysis","volume":"40","author":"Atripaldi","year":"2025","journal-title":"Int. J. Color. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Urraro, F., Nardone, V., Reginelli, A., Varelli, C., Angrisani, A., Patan\u00e8, V., D\u2019Ambrosio, L., Roccatagliata, P., Russo, G.M., and Gallo, L. (2021). MRI Radiomics in Prostate Cancer: A Reliability Study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.805137"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1007\/s00330-024-11327-w","article-title":"Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: A prospective validation study","volume":"35","author":"Dehghanpour","year":"2025","journal-title":"Eur. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e233459","DOI":"10.1148\/radiol.233459","article-title":"Multiparametric MRI for Bladder Cancer: A Practical Approach to the Clinical Application of VI-RADS","volume":"314","author":"Pecoraro","year":"2025","journal-title":"Radiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00330-025-11966-7","article-title":"VI-RADS quality score: Development and proposal of a scoring system by the American College of Radiology VI-RADS Steering Committee","volume":"36","author":"Woo","year":"2026","journal-title":"Eur. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dehghanpour, A., Davenport, M.S., Muglia, V.F., Nicola, R., Shen, L., Shinagare, A.B., Vargas, H.A., and Panebianco, V. (2025). Vesical Imaging Reporting and Data System: Overcoming Barriers to Global Implementation-AJR Expert Panel Narrative Review. AJR Am. J. Roentgenol.","DOI":"10.2214\/AJR.25.33634"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Panebianco, V., Briganti, A., Efstathiou, J.A., Galgano, S.J., Luk, L., Muglia, V.F., Redd, B., de Rooij, M., Takeuchi, M., and Woo, S. (2025). Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee. Eur. Urol.","DOI":"10.1016\/j.eururo.2025.10.010"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOU.0000000000001011","article-title":"The use of MRI in urothelial carcinoma","volume":"32","author":"Messina","year":"2022","journal-title":"Curr. Opin. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semradonc.2022.10.002","article-title":"Seeing is Believing: State of the Art Imaging of Bladder Cancer","volume":"33","author":"Messina","year":"2023","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1007\/s00330-023-09677-y","article-title":"VI-RADS for the diagnosis and management of urinary bladder cancer","volume":"33","author":"Panebianco","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41585-023-00830-2","article-title":"Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System","volume":"21","author":"Panebianco","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2024.09.013","article-title":"The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee","volume":"86","author":"Panebianco","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bju.16531","article-title":"VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: The \u2018CUT-less\u2019 Randomised Trial Protocol","volume":"135","author":"Vestri","year":"2025","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gulja\u0161, S., Dupan Krivdi\u0107, Z., Dre\u017enjak Maduni\u0107, M., \u0160ambi\u0107 Penc, M., Pavlovi\u0107, O., Krajina, V., Pavokovi\u0107, D., \u0160mit Taka\u010d, P., \u0160tefan\u010di\u0107, M., and Salha, T. (2023). Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate\u2014Unnecessary or Underutilised? A Narrative Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13223488"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3348\/kjr.2024.0767","article-title":"Discriminating Tumor Deposits From Metastatic Lymph Nodes in Rectal Cancer: A Pilot Study Utilizing Dynamic Contrast-Enhanced MRI","volume":"26","author":"Wu","year":"2025","journal-title":"Korean J. Radiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20475","DOI":"10.1038\/s41598-020-77331-4","article-title":"The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T1 relaxometry in patients with prostate cancer","volume":"10","author":"Sushentsev","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10334-023-01113-y","article-title":"The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS)","volume":"37","author":"Parillo","year":"2024","journal-title":"Magma"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.xkme.2020.10.001","article-title":"Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation","volume":"3","author":"Weinreb","year":"2021","journal-title":"Kidney Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2330036","DOI":"10.2214\/AJR.23.30036","article-title":"Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media","volume":"223","author":"Starekova","year":"2023","journal-title":"Am. J. Roentgenol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2054358118778573","DOI":"10.1177\/2054358118778573","article-title":"Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists","volume":"5","author":"Schieda","year":"2018","journal-title":"Can. J. Kidney Health Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00345-025-05951-4","article-title":"Diagnostic accuracy of biparametric vs. multiparametric MRI for clinically significant prostate cancer","volume":"43","author":"Pickersgill","year":"2025","journal-title":"World J. Urol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ma, J., Gu, X., Zhang, Z., Chen, J., Liu, Y., Qiu, Y., Ai, G., Jia, X., Li, Z., and Xiang, B. (2025). Advancing Prostate Cancer Assessment: A Biparametric MRI (T2WI and DWI\/ADC)-Based Radiomic Approach to Predict Tumor\u2013Stroma Ratio. Diagnostics, 15.","DOI":"10.3390\/diagnostics15212722"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bertelli, E., Vizzi, M., Marzi, C., Pastacaldi, S., Cinelli, A., Legato, M., Ruzga, R., Bardazzi, F., Valoriani, V., and Loverre, F. (2024). Biparametric vs. Multiparametric MRI in the Detection of Cancer in Transperineal Targeted-Biopsy-Proven Peripheral Prostate Cancer Lesions Classified as PI-RADS Score 3 or 3+1: The Added Value of ADC Quantification. Diagnostics, 14.","DOI":"10.3390\/diagnostics14151608"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1007\/s00261-025-04852-9","article-title":"Predicting variant histology in bladder cancer: The role of multiparametric MRI and vesical imaging-reporting and data system (VI-RADS)","volume":"50","author":"Aslan","year":"2025","journal-title":"Abdom. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nesiu, A., Novacescu, D., Latcu, S., Bardan, R., Cumpanas, A., Zara, F., Buciu, V., Caprariu, R., Cut, T.G., and Stana, A.H. (2025). Diagnostic Performance and Interobserver Agreement of the Vesical Imaging\u2013Reporting and Data System (VI-RADS) in Bladder Cancer Staging: A Systematic Review. Medicina, 61.","DOI":"10.3390\/medicina61030469"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e21200065","DOI":"10.14440\/bladder.0022","article-title":"Diagnostic accuracy of the Vesical Imaging Reporting and Data System for muscle-invasive bladder cancer and its role in reducing repeat transurethral resection of bladder tumor: A systematic review","volume":"12","author":"Nandi","year":"2025","journal-title":"Bladder"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euf.2023.08.004","article-title":"Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System","volume":"10","author":"Arita","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1038\/s41598-022-19273-7","article-title":"Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS","volume":"12","author":"Noh","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/curroncol30050350","article-title":"Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging","volume":"30","author":"Tyagi","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_47","first-page":"e88623","article-title":"Emerging Role of Multiparametric MRI in the Staging of Bladder Cancer: Insights From the BladderPath Trial","volume":"17","author":"Akintelure","year":"2025","journal-title":"Cureus"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1002\/cam4.5782","article-title":"Multiple directional DWI combined with T2WI in predicting muscle layer and Ki-67 correlation in bladder cancer in 3.0-T MRI","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"106973","DOI":"10.1016\/j.crad.2025.106973","article-title":"Morphological changes in the muscle layer associated with invasion of bladder cancer","volume":"87","author":"Ohta","year":"2025","journal-title":"Clin. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00261-013-0038-0","article-title":"Diffusion-weighted MRI in bladder carcinoma: The differentiation between tumor recurrence and benign changes after resection","volume":"39","author":"Wang","year":"2014","journal-title":"Abdom. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Napolitano, L., Ippoliti, S., Fletcher, P., Caruso, M., Cirillo, L., Miano, R., Finazzi Agr\u00f2, E., La Rocca, R., Fusco, F., and Arcaniolo, D. (2023). Diagnostic Protocol, Outcomes and Future Perspectives of the Vesical Imaging-Reporting and Data Systems (VI-RADS), a Narrative Review. Appl. Sci., 13.","DOI":"10.3390\/app13127331"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40644-025-00831-x","article-title":"Evaluating biparametric MRI for diagnosing muscle-invasive bladder cancer with variant urothelial histology: A multicenter study","volume":"25","author":"Liu","year":"2025","journal-title":"Cancer Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2214\/AJR.20.23604","article-title":"VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study","volume":"216","author":"Ueno","year":"2020","journal-title":"Am. J. Roentgenol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1007\/s00330-022-08766-8","article-title":"The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program","volume":"32","author":"Pecoraro","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00345-022-03969-6","article-title":"The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): An updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations","volume":"40","author":"Flammia","year":"2022","journal-title":"World J. Urol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1007\/s00261-024-04235-6","article-title":"Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT)","volume":"49","author":"Khwaja","year":"2024","journal-title":"Abdom. Radiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines","volume":"87","author":"Bruins","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting and Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur. Urol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:54:42Z","timestamp":1773924882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/6\/999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18060999"],"URL":"https:\/\/doi.org\/10.3390\/cancers18060999","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}